AKI in this setting is thus an extremely complex process involving multiple pathophysiologic pathways, among which glycogen synthase kinase 3β (GSK3β) has emerged as a key factor mediating the pathogenesis of AKI. This evidence concerns the gene GSK3B and acute kidney injury.